Inhibition of tumor growth by heparins in vivo


https://doi.org/10.4081/hmr.v1i9.333
Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005
Published: June 3, 2009
Abstract Views: 113
PDF: 163
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Unfractionated Heparin (UFH) and its improved version LMWH are known to have poly-pharmacological activity at various levels. Earlier studies have focused on the plasma anti-Xa and anti-IIa pharmacodynamics (PD) of the different LMWH. Other important PD parameters for heparin and LMWH might explain the diverse clinical impacts of this class of agents in thrombosis and beyond. These diverse pharmacological actions include stimulation of the release of the vascular tissue factor pathway inhibitor (TFPI), inhibition of inflammation (via NFkappaB), inhibition of key matrix degrading enzymes, inhibition of platelet-cancer cell adhesion, and other mechanisms.

Supporting Agencies


Mousa, S. (2009). Inhibition of tumor growth by heparins in vivo. Hematology Meeting Reports (formerly Haematologica Reports), 1(9). https://doi.org/10.4081/hmr.v1i9.333
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC